Esperion(ESPR) - 2024 Q1 - Earnings Call Transcript

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q1 2024 Earnings Conference Call May 7, 2024 8:00 AM ET Company Participants Tiffany Aldrich - Associate Director, Corporate Communications Sheldon Koenig - President & Chief Executive Officer Ben Halladay - Chief Financial Officer Eric Warren - Chief Commercial Officer JoAnne Foody - Chief Medical Officer Conference Call Participants Dennis Ding - Jefferies Serge Belanger - Needham Tom Shrader - BTIG Jessica Fye - JPMorgan Joe Pantginis - H.C. Wainwright Jason Zema ...